OSI Pharmaceuticals(美国)

OSI Pharmaceuticals

美国OSIPharmaceuticalswww.osip.comOSIPharmaceuticalsInc.致力于通过发现、开发和销售高质量、创新和差异化的靶向治疗药物，延长癌症和糖尿病、肥胖症患者的生命并改善患者的生活质量，实现“调整药物和改善生活”的目的。OSIPharmaceuticals是的生物科技企业，主要研究、开发和销售高质量药品，延长全球癌症和糖尿病患者的生命 或改善其生活质量。2010年日药商Astellas40亿美元收购美生物技术公司OSI armaceuticalsiscommittedto“shapingmedicineandchanginglives”bydiscovering,developingandcommercializinghigh-quality,novelanddifferentiatedpersonalizedmedicinesdesignedtoextendlifeandimprovethequalityoflifeforpatientswithcanceranddiabetes/obesity.Wespecializeinthediscoveryanddevelopmentofinnovativemoleculartargetedtherapiesthataddresssignificantunmetmedicalneeds,andstrivetoturnpioneeringscienceintobreakthroughtherapiesforpatientssufferingfromlife-threateningdiseases.OurOncologybusinessisanchoredbyourflagshipproduct,Tarceva®(erlotinib),asmallmolecul